Synergistic effect of gold nanoparticles anchored on conductive carbon black as an efficient electrochemical sensor for sensitive detection of anti-COVID-19 drug Favipiravir in absence and presence of co-administered drug Paracetamol.

Favipiravir (FVP) is introduced as a promising newly developed antiviral drug against the coronavirus disease 2019 (COVID-19). Therefore, the accurate determination of FVP is of great significance for quality assessment and clinical diagnosis. Herein, a novel electrochemical sensing platform for FVP based on gold nanoparticles anchored conductive carbon black (Au@CCB) modified graphite nanopowder flakes paste electrode (GNFPE) was constructed. Morphological and nanostructure properties of Au@CCB have been investigated by TEM, HRTEM, and EDX methods. The morphology and electrochemical properties of Au@CCB/GNFPE were characterized by SEM, cyclic voltammetry (CV), and EIS. The Au@CCB nanostructured modified GNFPE exhibited strong electro-catalytic ability towards the oxidation of FVP. The performance of the fabricated Au@CCB/GNFPE was examined by monitoring FVP concentrations in the absence and presence of co-administered drug paracetamol (PCT) by AdS-SWV. It was demonstrated that the proposed sensor exhibited superior sensitivity, stability, and anti-interference capability for the detection of FVP. The simultaneous determination of a binary mixture containing FVP and the co-administered drug PCT using Au@CCB/GNFPE sensor is reported for the first time. Under optimized conditions, the developed sensor exhibited sensitive voltammetric responses to FVP and PCT with low detection limits of 7.5 nM and 4.3 nM, respectively. The sensing electrode was successfully used to determine FVP and PCT simultaneously in spiked human plasma and pharmaceutical preparations, and the findings were satisfactory. Finally, the fabricated sensor exhibited high sensitivity for simultaneous detection of FVP and PCT in the presence of ascorbic acid in a real sample.

Green ecofriendly electrochemical sensing platform for the sensitive determination of doxycycline.

The detection of pharmaceutical compounds in extremely low concentrations remains a challenge despite recent advancements in electrochemical sensing. In this study, a green hydrothermally synthesized nickel hydroxide-graphene hybrid material was used for the point-of-care determination of the antibiotic doxycycline (DOXY), which is a promising treatment for COVID-19 and other infections. The electrochemical sensor, based on a screen-printed electrode modified with the hybrid material, was able to detect DOXY in the range of 5.1 × 10-8 to 1.0 × 10-4 M, with a low detection limit of 9.6 × 10-9 M. This approach paves the way for eco-friendly and sustainable methods of nanomaterial synthesis for electrochemical analyses, particularly in point-of-care drug monitoring, and has the potential to improve access to testing platforms.

Bifunctional ratiometric sensor based on highly fluorescent nitrogen and sulfur biomass-derived carbon nanodots fabricated from manufactured dairy product as a precursor.

Novel biomass-derived carbon dots co-doped with nitrogen and sulfur were fabricated through facile and simple synthetic method from manufactured milk powder and methionine as precursors. The as-fabricated platform was used for ratiometric fluorescence sensing of Cu (II) and bisphosphonate drug risedronate sodium. The sensing platform is based on oxidation of o-phenylenediamine by Cu (II) to form 2, 3-diaminophenazine (oxidized product) with an emission peak at 557 nm. The resultant product quenched the fluorescence emission of as-fabricated carbon dots at 470 nm through Förster resonance energy transfer (FRET) and inner-filter effect (IFE). Upon addition of risedronate sodium, the formation of 2, 3-diaminophenazine was decreased as a result of Cu (II) chelation with risedronate sodium, recovering the fluorescence emission of carbon dots. The ratio of fluorescence at 470 nm and 557 nm was measured as a function of Cu (II) and risedronate sodium concentrations. The proposed sensing platform sensitively detected Cu (II) and risedronate sodium in the range of 0.01-55 µM and 5.02-883 µM with LODs (S/N = 3) of 0.003 µM and 1.48 µM, respectively. The sensing platform exhibited a good selectivity towards Cu (II) and risedronate sodium. The sensing system was used to determine Cu (II) and risedronate sodium in different sample matrices with recoveries % in the range of 99-103 % and 97.4-103.8 %, and RSDs % in the range of 1.5-3.0 % and 1.8-3.6 %, respectively.